Skip to main content

FDA Registration Assistance

FDA Import Alert 54-16 dietary supplements containing active pharmaceutical ingredients
FDA Import Alerts · Supplements
Last updated:

FDA Import Alert 54-16: Supplements With Hidden Drug Ingredients

Import Alert 54-16 lets FDA detain products sold as foods or dietary supplements from listed firms without examining them when testing has found a drug ingredient inside. Sexual enhancement, weight loss and muscle building products are the most common. Removal takes analytical data and labels that show the drug is gone for good.

Short answer: FDA Import Alert 54-16 allows detention without physical examination of products marketed as foods, including dietary supplements, from listed firms when they contain an active pharmaceutical ingredient (API) or an analogue, such as sildenafil or sibutramine. Depending on the labeling, FDA charges them as unapproved and misbranded drugs or as adulterated food. To get off the Red List, the firm shows FDA the cause is resolved, with analytical data, labels and labeling, by email to Importalerts2@fda.hhs.gov.

Listed on 54-16? Send us the firm name, product and ingredient found. We review the finding and plan the removal request.

Get a 54-16 Case Review
At a Glance

Import Alert 54-16 Basics

ItemImport Alert 54-16
Official titleDWPE of Products Marketed as Foods, Including Dietary Supplements, That Contain an API
Drug chargesUnapproved new drug 505(a); misbranded 502(f)(1)
Food chargesPoisonous 402(a)(1); unsafe food additive 402(a)(2)(C)
Removal reviewFDA reviews analytical data, labels and labeling
Countries19 countries and territories on the Red List
Removal contactImportalerts2@fda.hhs.gov

Details follow the current text of Import Alert 54-16, published October 15, 2026.

Listed Products

Products Most Often Listed for Hidden Drugs

Sexual enhancement

Capsules, honey sachets and coffees with sildenafil-type PDE-5 drugs.

Weight loss

Slimming products with sibutramine and similar drugs.

Muscle building

Products with anabolic steroids or novel synthetic steroids.

Joint and pain

Products with prescription NSAIDs such as indomethacin.

Honey products

Royal honey and honey-based products with drug ingredients.

Herbal products

Herbal pastes, teas and botanicals with added drugs.

Drug Ingredients

APIs Named in Import Alert 54-16

Drug typeExample
PDE-5 inhibitorsSildenafil
Withdrawn drugsSibutramine
AnticoagulantsWarfarin
AnticonvulsantsPhenytoin
StatinsLovastatin
Prescription NSAIDsIndomethacin
Beta-blockersPropranolol
Controlled substancesBenzodiazepines, anabolic steroids
Release and Removal

Two Tracks: Releasing a Shipment vs Leaving the List

Release one shipment

The alert does not set a release testing protocol. The owner or consignee presents evidence that the product complies, usually lab analysis and labeling, to the FDA Division compliance office named in the notice of detention. A product with a drug ingredient cannot be sold as a supplement.

Removal from the Red List

Evidence the conditions behind the violation are resolved, including analytical data, labels and labeling for FDA to review, emailed to Importalerts2@fda.hhs.gov under RPM Chapter 9-8.

Need samples pulled and tested for a detained supplement shipment? Our sister company, FDA Detention Sampling, coordinates sample collection, chain of custody and testing with LAAF-accredited laboratories nationwide. Call +1 (786) 561-3726.

Removal Evidence

What a Strong 54-16 Request Includes

  • The product, entry and drug ingredient behind the listing.
  • How the drug got into the product: formula, supplier or contract manufacturer.
  • The reformulated product and new supplier controls.
  • Lab analysis of new lots showing no API or analogue.
  • Revised labels and labeling with no drug claims.
How It Works

Our Import Alert 54-16 Process

1
Confirm the listingWe check the Red List entry, product and ingredient behind it.
2
Root cause reviewWe trace how the drug got into the product.
3
Testing planWe help plan analysis of new lots for the API and analogues.
4
Evidence packageWe assemble the formula, supplier records, lab data and labels.
5
Request and follow-upWe send it to Importalerts2@fda.hhs.gov and answer FDA questions.

FDA's framework is in RPM Chapter 9-8; FDA removal guidance explains what a request should include.

Related Help

Import Alert Resources

Import Alert Removal

Removal help for food and supplements.

Dietary Supplements

Supplement registration and labeling.

Supplement Label Review

Check claims and ingredient labeling.

Import Alert 45-02

Illegal and undeclared colors.

Import Alert 99-42

Heavy metals in food and supplements.

Release a Held Shipment

FDA hold statuses and release steps.

Start With the Listing

Get Help With Import Alert 54-16

We review the drug finding, trace the root cause, plan new lot testing and prepare the removal request. We are an independent compliance firm, not FDA or a law firm, and no one can guarantee FDA's decision.

  • Custom-scoped quote based on your listing and products.
  • Exporters, manufacturers and U.S. importers.
  • Agree the scope and pricing before any paid work begins.

Contact our specialists, email info@fdaregistrationassistance.com, or call +1 (928) 275-8333. Import alert removal · Supplement services · Contact.

Get a 54-16 Case Review

FDA Registration Assistance is a private consulting firm, not FDA or any government agency. FDA registration is not FDA approval, clearance or certification.

FAQ

Frequently Asked Questions — Import Alert 54-16

What is FDA Import Alert 54-16?

Import Alert 54-16 is titled "Detention Without Physical Examination of Products That Are Marketed as Foods, Including Products Marketed as Dietary Supplements, That Contain an Active Pharmaceutical Ingredient." It lets FDA detain listed products without examining each shipment because earlier testing found drug ingredients.

Which drug ingredients does FDA find in 54-16 products?

The alert names PDE-5 inhibitors such as sildenafil, withdrawn drugs such as sibutramine, anticoagulants such as warfarin, anticonvulsants such as phenytoin, statins such as lovastatin, prescription NSAIDs such as indomethacin, beta-blockers such as propranolol, controlled substances including benzodiazepines and anabolic steroids, and novel synthetic steroids.

Which products are most often on 54-16?

Products promoted for sexual enhancement, weight loss and muscle building, plus honey and royal honey products, herbal coffees, slimming teas, herbal pastes and vitamin and mineral products. The Red List covers 19 countries and territories.

What are the charges under Import Alert 54-16?

If the labeling shows drug use, the product is charged as an unapproved new drug under section 505(a) and a misbranded drug under section 502(f)(1). If it does not, it is charged as adulterated food under section 402(a)(1) (poisonous or deleterious substance) and section 402(a)(2)(C) (unsafe food additive). Refusal is under section 801(a)(3).

Why does FDA treat these products as drugs?

FDA says these APIs are not safe except under the supervision of a licensed practitioner. A product that contains the same ingredient as an approved drug, or an analogue of it, cannot be sold as a food or supplement unless it is covered by an approved application.

Can a product with an API be sold as a dietary supplement?

No. An ingredient approved as a drug generally cannot be in a dietary supplement. The product would need FDA drug approval to be sold legally. See our dietary supplements page.

How do I know if my firm is on Import Alert 54-16?

Open Import Alert 54-16 and search the Red List by country and firm name. Each entry shows the product and the date it was added. Check before every shipment season, since the alert is updated often.

How can a detained 54-16 shipment be released?

The alert does not set a release testing protocol. The owner or consignee can present evidence such as lab analysis and labeling to the FDA Division compliance office named in the notice. A product that actually contains a drug ingredient will not be released as a supplement.

How do I get my firm removed from Import Alert 54-16?

Submit evidence that the conditions that caused the violation have been resolved, so FDA can be confident future entries will comply. FDA says it reviews the analytical data, labels and labeling sent in support of removal. Send the request to Importalerts2@fda.hhs.gov.

What evidence supports a 54-16 removal request?

A root cause investigation showing how the drug got into the product, the reformulated product, new supplier and contract manufacturer controls, lab analysis of new lots for the API and its analogues, and revised labels with no drug claims.

Why test for analogues and not just the named drug?

FDA found that many products contain analogues of approved drugs, chemically altered versions that standard tests may miss. A testing plan should cover the drug class, not just one compound.

What happened to the old Import Alert 54-08?

Some firms on 54-16 were previously listed on Import Alert 54-08, which has been deactivated, for the presence of digitalis.

Who do I contact at FDA about Import Alert 54-16?

Removal requests go to Importalerts2@fda.hhs.gov. The alert lists the Division of Import Operations at (301) 796-0356 and FDAPRIVATELABIMPORTALERTS@fda.hhs.gov for sampling and analytical methods.

What does the U.S. importer need to do?

Importers must keep a Foreign Supplier Verification Program that covers undeclared drug ingredients where it is a known or reasonably foreseeable hazard, with supplier verification and testing for higher-risk products. See our FSVP service.

Can you guarantee removal from Import Alert 54-16?

No. FDA makes every removal decision. We are an independent compliance firm, not FDA or a law firm. We help you build a complete, well-documented request.

HM
Reviewed By Hector Matos, Senior Regulatory Compliance Specialist · 15+ years FDA compliance experience · Updated October 2026
Discuss Your Project

Request an Import Alert 54-16 Case Review

Tell us what your company makes, sells, or distributes, where each product is manufactured or packed, your U.S. importer or buyer arrangement, label readiness, and target shipment date.

Submitting this inquiry does not purchase a service or authorize paid work. Our team can discuss the scope and required materials before you commission assistance. Fields marked with an asterisk are required.

Please do not include payment details, medical records, or other sensitive information. You can also email our team or call +1 (928) 275-8333.